Translational Science Interagency Fellow

Therapeutic Development Branch  
Division of Preclinical Innovation  
National Center for Advancing Translational Sciences  
National Institutes of Health

Biography

Elia R. Lopez, Ph.D.

Elia R. Lopez completed her postdoctoral training as a Translational Science Interagency Fellow (TSIF) from 2021 to 2024 under the mentorship of Donald C. Lo, Ph.D., and Bryan Traynor, M.D., Ph.D. (National Center for Advancing Translational Science, National Institutes of Health, NCATS/NIH) and Lois Freed, Ph.D., and James Wild, Ph.D. (United States Food and Drug Administration, FDA). Lopez’s research explored translational approaches to optimize safety and toxicology testing of antisense oligonucleotides (ASOs) for treatment of rare monogenic diseases.

Lopez earned a Ph.D. in biomedical sciences with a focus in biochemistry and cell biology from the University of Texas Health Science Center at Houston.

Select Publications

1. Odem MA, Bavencoffe AG, Cassidy RM, et al. Isolated nociceptors reveal multiple specializations for generating irregular ongoing activity associated with ongoing pain. Pain. 2018;159(11):2347-2362. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6193853/
2. Lopez ER, Carbajal AG, Tian JB, et al. Serotonin enhances depolarizing spontaneous fluctuations, excitability, and ongoing activity in isolated rat DRG neurons via 5-HT₄ receptors and cAMP-dependent mechanisms. Neuropharmacology. 2021;184:108408. Available from: https://www.sciencedirect.com/science/article/pii/S0028390820304767